Metastatic melanoma: can FDG-PET predict success of anti-PD-1 therapy and help determine when it can be discontinued?

Saved in:

Bibliographic Details
Published in:	European journal of nuclear medicine and molecular imaging Vol. 47; no. 10; pp. 2227 - 2232
Main Author:	Hindié, Elif
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 01.09.2020 Springer Nature B.V
Subjects:	Cardiology CTLA-4 Antigen - therapeutic use Editorial Fluorodeoxyglucose F18 Humans Imaging Immune Checkpoint Inhibitors Immunotherapy Medicine Medicine & Public Health Melanoma Melanoma - diagnostic imaging Melanoma - drug therapy Metastases Nuclear Medicine Oncology Oncology – Chest Orthopedics PD-1 protein Positron-Emission Tomography Prognosis Programmed Cell Death 1 Receptor Radiology Skin Neoplasms - diagnostic imaging Skin Neoplasms - drug therapy
ISSN:	1619-7070, 1619-7089, 1619-7089
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!